MangoceuticalsMGRX +3.32%26 OCF Margin % is -1,927.94% as of Mar. 2026. GuruFocus rates MGRX with a GF Score™ of 26/100 and a GF Value™ of $0.31 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Mangoceuticals ranks worse than 97.76% on this metric.
The historical rank and industry rank for Mangoceuticals's OCF Margin % or its related term are showing as below:
MGRX'
s OCF Margin % Range Over the Past 10 Years
Min: -14966.67 Med: -1120.04 Max: -789.61
Current: -1180.19
During the past 5 years, the highest OCF Margin % of Mangoceuticals was -789.61%. The lowest was -14966.67%. And the median was -1120.04%.
MGRX's OCF Margin % is ranked worse than 97.76% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 8.29
vs MGRX: -1180.19
Mangoceuticals OCF Margin % Related Terms
Mangoceuticals OCF Margin % Historical Data
* Premium members only.
The historical data trend for Mangoceuticals's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Mangoceuticals's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mangoceuticals OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mangoceuticals's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Mangoceuticals's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mangoceuticals (MGRX) has a OCF Margin % of -1,927.94% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Mangoceuticals and its competitors. According to the industry distribution chart, Mangoceuticals ranks #654 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 97.8%.
Is Mangoceuticals' OCF Margin % too high?
Mangoceuticals' current OCF Margin % is -1,927.94%. Based on the distribution chart, Mangoceuticals ranks #654 out of 669 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Mangoceuticals has a GF Score™ of 26/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mangoceuticals' OCF Margin % compare to WLSS and BRGX?
According to the Healthcare Providers & Services industry distribution chart, Mangoceuticals ranks #654 out of 669 companies for OCF Margin %. This places Mangoceuticals in the lower half of its industry. The industry median OCF Margin % is 8.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.29, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Mangoceuticals and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mangoceuticals's current OCF Margin % is -1,927.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mangoceuticals stock overvalued right now?
Based on GuruFocus' analysis, Mangoceuticals (MGRX) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.31, compared to a current price of $0.36 — trading 16.8% above its estimated fair value. The current OCF Margin % is -1,927.94%. Mangoceuticals' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Mangoceuticals (MGRX), the current OCF Margin % is -1,927.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mangoceuticals (MGRX) Overvalued in 2026?
Based on GuruFocus' analysis, Mangoceuticals stock appears to be overvalued.
The current stock price of $0.36 is trading 16.8% above its estimated GF Value™ of $0.31.
GuruFocus considers Mangoceuticals to be Modestly Overvalued.
Key valuation signals for MGRX:
OCF Margin %: -1,927.94%
GF Value™: $0.31 vs. price of $0.36 (16.8% above fair value)
No single metric tells the full story. See the MGRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
26GF Score
Get the complete analysis for MGRX
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MGRX has been successfully added to your 
